{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:48:20Z","timestamp":1764251300983},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T00:00:00Z","timestamp":1337212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Strong acid inhibition using esomeprazole increases cure rates with triple therapy and 10\u2010day treatments are more effective than 7\u2010day ones. The combination of amoxicillin plus metronidazole at full doses, and using a physiologically\u2010correct schedule three times a day, and has been shown to overcome metronidazole resistance and to achieve good eradication rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To assess the eradication rate of a new first\u2010line treatment regimen associating strong acid inhibition, amoxicillin and metronidazole and to evaluate tolerance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients from eight hospitals were included. <jats:italic><jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>elicobacter pylori<\/jats:italic> status was assessed by at least one of the following: histology, culture, rapid urease test or urea breath test (<jats:styled-content style=\"fixed-case\">UBT<\/jats:styled-content>). Ten\u2010day treatment was prescribed comprising esomeprazole 40\u00a0mg twice a day plus amoxicillin 1\u00a0g and metronidazol 500\u00a0mg both three times a day. <jats:italic><jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>elicobacter pylori<\/jats:italic> cure was assessed by <jats:styled-content style=\"fixed-case\">UBT<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A hundred and thirty\u2010six patients were enrolled. Mean age was 52.6\u00a0\u00b1\u00a016\u00a0years and 59.6% of patients were men. Main indications for treatment were: uninvestigated dyspepsia (13.6%); functional dyspepsia (18.2%); gastric ulcer (21.8%); and duodenal ulcer (39.8%). <jats:italic><jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>elicobacter pylori<\/jats:italic> eradication was achieved in 112 of the 127 patients who returned for follow\u2010up. Eradication rates were 82.4% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 74.7\u201388.1) by intention\u2010to\u2010treat analysis and 88.2% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 81.2\u201392.8) by per protocol. Treatment was well tolerated and no major side effects were reported. Nine patients complained of mild side effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Cure rates of the combination of esomeprazole, amoxicillin and metronidazole are high and the treatment was well tolerated. This pilot study warrants the comparison of this schedule with current standards.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2012.05137.x","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T17:35:03Z","timestamp":1337276103000},"page":"190-196","source":"Crossref","is-referenced-by-count":22,"title":["High\u2010dose, ten\u2010day esomeprazole, amoxicillin and metronidazole triple therapy achieves high <i><scp>H<\/scp>elicobacter pylori<\/i> eradication rates"],"prefix":"10.1111","volume":"36","author":[{"given":"J.","family":"S\u00e1nchez\u2010Delgado","sequence":"first","affiliation":[{"name":"Gastroenterology Unit Hospital Parc Taul\u00ed Departament de Medicina Universitat Aut\u00f2noma de Barcelona Sabadell Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Garc\u00eda\u2010Iglesias","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital Parc Taul\u00ed Departament de Medicina Universitat Aut\u00f2noma de Barcelona Sabadell Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Castro\u2010Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain"},{"name":"Gastroenterology Unit Hospital Ntra. Sra. de Valme Sevilla Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bory","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital del Mar Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Barenys","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital de Viladecans Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bujanda","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain"},{"name":"Gastroenterology Unit Hospital de Donostia University of Country Basque San Sebasti\u00e1n Guip\u00fazcoa Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lisozain","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital de Donostia University of Country Basque San Sebasti\u00e1n Guip\u00fazcoa Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Calvo","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital de Mondrag\u00f3n Guip\u00fazcoa Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Torra","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Parc Sanitari Sant Joan de D\u00e9u Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain"},{"name":"Hospital de la Princesa Instituto de Investigaci\u00f3n Sanitaria Princesa (IP) Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Calvet","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit Hospital Parc Taul\u00ed Departament de Medicina Universitat Aut\u00f2noma de Barcelona Sabadell Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02248.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.022111"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60020-2"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656561003657152"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0b013e3181c8a1a3","article-title":"Sequential therapy for Helicobacter pylori eradication: a critical review","volume":"44","author":"Gisbert JP","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60825-8"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.5.869"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.2.166"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00770.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i16.2477"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199901000-00005"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00281.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03807.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90095-G"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf046"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04274.x"},{"key":"e_1_2_6_20_1","first-page":"179","article-title":"Eficacia del tratamiento emp\u00edrico cu\u00e1druple \u201cconcomitante\u201d para la infecci\u00f3n por H.pylori en un \u00e1rea con una tasa elevada de resistencia a claritromicina","volume":"34","author":"Molina Infante J","year":"2011","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2747"},{"key":"e_1_2_6_22_1","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De FV","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00468-X"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.2807\/esm.12.07.00721-en"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328338e43d"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09674845.2006.11732730","article-title":"Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates","volume":"63","author":"Hooton C","year":"2006","journal-title":"Br J Biomed Sci"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.720100000.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.139315000.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00349.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70633-X"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2008.S56"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199506002-00029"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00508.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00980.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03094.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00717.x"},{"issue":"1","key":"e_1_2_6_37_1","first-page":"13","article-title":"What is potent acid inhibition, and how can it be achieved?","volume":"65","author":"Calvet X","year":"2005","journal-title":"Drugs"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0576-5"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1006158"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1155\/2003\/714124"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00744.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00008"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100960000288"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2012.05137.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2012.05137.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T02:56:44Z","timestamp":1698721004000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2012.05137.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,17]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-2036.2012.05137.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05137.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,17]]}}}